ArticleCancers2023
Kidney Cancer Diagnosis and Surgery Selection by Machine Learning from CT Scans Combined with Clinical Metadata.
Article in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 3 syntheses or guidelines pooled it, 63 citations in OpenAlex.
- Performance of Machine Learning Models Based on Medical Imaging in Predicting Pathological Grade of Clear Cell Renal Cell Carcinoma.Cancer medicine · 2026Pooled it
- Artificial intelligence in the radiologic diagnosis of major urological cancers: a meta-analysis.World journal of urology · 2026Pooled it
- Diagnostic performance of artificial intelligence in detection of renal cell carcinoma: a systematic review and meta-analysis.BMC cancer · 2025Pooled it
- Advancing early detection of chromophobe renal cell carcinoma: a Bayesian optimization approach to machine learning models.Scientific reports · 2026Article
- Enhanced Feature Extraction for Detection and Classification of Kidney Abnormalities.Current medical imaging · 2026Article
- From Radiomics to Radiogenomics: Decoding Renal Cell Carcinoma Biology for Precision Medicine-a narrative review.Insights into imaging · 2025Review
- Kidney cancer diagnosis and surgery selection by double decker convolutional neural network from CT scans combined with great wall construction algorithm.Abdominal radiology (New York) · 2025Article
- A phase-aware Cross-Scale U-MAMba with uncertainty-aware segmentation and Switch Atrous Bifovea EfficientNetB7 classification of kidney lesion subtype.Lasers in medical science · 2025Article
- Optimized machine learning based comparative analysis of predictive models for classification of kidney tumors.Scientific reports · 2025Article
- Kidney Disease Segmentation and Classification Using Firefly Sigma Seeker and MagWeight Rank Techniques.Bioengineering (Basel, Switzerland) · 2025Article
- Artificial Intelligence-Augmented Advancements in the Diagnostic Challenges Within Renal Cell Carcinoma.Journal of clinical medicine · 2025Review
- Smart nanomedicines powered by artificial intelligence: a breakthrough in lung cancer diagnosis and treatment.Medical oncology (Northwood, London, England) · 2025Review
- An attention enhanced dilated bottleneck network for kidney disease classification.Scientific reports · 2025Article
- Analyzing Online Search Trends for Kidney, Prostate, and Bladder Cancers in China: Infodemiology Study Using Baidu Search Data (2011-2023).JMIR cancer · 2025Article
- Preoperative kidney tumor risk estimation with AI: From logistic regression to transformer.PloS one · 2025Article
- Artificial Intelligence-Based Classification of CT Images Using a Hybrid SpinalZFNet.Interdisciplinary sciences, computational life sciences · 2024Article
- Source free domain adaptation for kidney and tumor image segmentation with wavelet style mining.Scientific reports · 2024Article
- Applications of artificial intelligence in urologic oncology.Investigative and clinical urology · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 4 institutions in 2 countries.
Funding
Abstract
Kidney cancers are one of the most common malignancies worldwide. Accurate diagnosis is a critical step in the management of kidney cancer patients and is influenced by multiple factors including tumor size or volume, cancer types and stages, etc. For malignant tumors, partial or radical surgery of the kidney might be required, but for clinicians, the basis for making this decision is often unclear. Partial nephrectomy could result in patient death due to cancer if kidney removal was necessary, whereas radical nephrectomy in less severe cases could resign patients to lifelong dialysis or need for future transplantation without sufficient cause. Using machine learning to consider clinical data alongside computed tomography images could potentially help resolve some of these surgical ambiguities, by enabling a more robust classification of kidney cancers and selection of optimal surgical approaches. In this study, we used the publicly available KiTS dataset of contrast-enhanced CT images and corresponding patient metadata to differentiate four major classes of kidney cancer: clear cell (ccRCC), chromophobe (chRCC), papillary (pRCC) renal cell carcinoma, and oncocytoma (ONC). We rationalized these data to overcome the high field of view (FoV), extract tumor regions of interest (ROIs), classify patients using deep machine-learning models, and extract/post-process CT image features for combination with clinical data. Regardless of marked data imbalance, our combined approach achieved a high level of performance (85.66% accuracy, 84.18% precision, 85.66% recall, and 84.92% F1-score). When selecting surgical procedures for malignant tumors (RCC), our method proved even more reliable (90.63% accuracy, 90.83% precision, 90.61% recall, and 90.50% F1-score). Using feature ranking, we confirmed that tumor volume and cancer stage are the most relevant clinical features for predicting surgical procedures. Once fully mature, the approach we propose could be used to assist surgeons in performing nephrectomies by guiding the choices of optimal procedures in individual patients with kidney cancer.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.